Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(APLIF)$0.68-Covid 19 Drug with Phase 3 data expected within 2 months ...this unknown gem could be the next Highflyer like NVAX or BNTX...Market cap is only $45 million
(SNPX) MC $24 m--Float 1m --BIG Alzheimer Drug in Phase 2b with data coming soon ..this is definitely the CHEAPEST Alzheimer gem you can get .this could fly like ANVS did or even harder because of its low float . SNPX just start trading on Nasdaq this week so its still under radar stock .
Presentation
https://ir.synaptogen.com/assets/uploads/2021/03/Synaptogenix-Corporate-Deck.pdf
(ETON)2x FDA Decisions within 2 months the first one in 2 weeks
upcoming pdufa dates :
*June 18: Ready-to-Use Ephedrine Injection
*August 6: Topiramate Oral Solution
(ETON)2x FDA Decisions within 2 months the first one in 2 weeks
upcoming pdufa dates :
*June 18: Ready-to-Use Ephedrine Injection
*August 6: Topiramate Oral Solution
(ETON)FDA Decision in 11 DAYS
(LMNL)FDA Decision NEXT Week = $$$
(LMNL) FDA Decision next Week =$$$$$$$$
(LMNL)$4.50-FDA Decision NEXT week ..could explode to $10 or more on approval
PDUFA Target Action Date of June 5, 2021 for Ryplazim® (plasminogen) BLA Submission
(LMNL)$4.50-FDA Decision NEXT week ..could explode to $10 or more on approval
PDUFA Target Action Date of June 5, 2021 for Ryplazim® (plasminogen) BLA Submission
(LMNL)$4.50-FDA Decision NEXT week ..could explode to $10 or more on approval
PDUFA Target Action Date of June 5, 2021 for Ryplazim® (plasminogen) BLA Submission
(EYEN) Phase 3 data WITHIN days ,positive results could push this low float stock toward 10 bucks or even higher . They have another Drug awaiting FDA approval expected in October .More information in the presentation below .GLTA
New Presentation
https://ir.eyenovia.com/static-files/4495721a-a6ae-4e0c-8f84-8cec5e110a97
Completes patient enrollment in Phase 3 VISION-1 study evaluating MicroLine for the treatment of presbyopia; topline data on track for Q2
MydCombi expected PDUFA date of October 28, 2021
(EYEN) Phase 3 data WITHIN days ,positive results could push this low float stock toward 10 bucks or even higher . They have another Drug awaiting FDA approval expected in October .More information in the presentation below .GLTA
New Presentation
https://ir.eyenovia.com/static-files/4495721a-a6ae-4e0c-8f84-8cec5e110a97
Completes patient enrollment in Phase 3 VISION-1 study evaluating MicroLine for the treatment of presbyopia; topline data on track for Q2
MydCombi expected PDUFA date of October 28, 2021
(ESOA) MC 27 m-Revenue 120 m -Float 5 m ..Price $2.03 this one also looks great one of the cheapes gem in the energy sector .
(SOWG) MC $15 M -800k float NEW company with massive upside could run to $20 or more ..GLTA
https://finance.yahoo.com/news/black-ridge-oil-gas-becomes-130000580.html
Sow Good will launch its line of freeze-dried snacks, smoothies and soups, and its direct-to-consumer focused website, to coincide with initial production from its state-of-the-art facility located in Irving, Texas. Sow Good expects to begin production in the first quarter of 2021. Investors are welcomed to visit www.thisissowgood.com to follow product launch updates.
Sow Good's unique food products are targeting the large, and growing, freeze-dried food products market. The global freeze-dried food products market is estimated by Technavio to total nearly $60B in 2020, with the United States representing almost 30% of the total. Technavio further projects market growth to continue at over 8% per year through 2024.
Sow Good management is well positioned to lead the Company's growth. As announced in October, Claudia and Ira Goldfarb joined Sow Good as CEO and Executive Chairman, respectively. The Goldfarb's have extensive experience with freeze-dried manufacturing and in building food product-focused companies. The Company further announced in October that it has appointed Greg Creed, a veteran restaurant executive, to the Company's Board of Directors. Mr. Creed most recently held the position of CEO of Yum! Brands, Inc., and previously led Taco Bell as its CEO.
(SOWG) MC $15 M -800k float NEW company with massive upside could run to $20 or more ..GLTA
https://finance.yahoo.com/news/black-ridge-oil-gas-becomes-130000580.html
Sow Good will launch its line of freeze-dried snacks, smoothies and soups, and its direct-to-consumer focused website, to coincide with initial production from its state-of-the-art facility located in Irving, Texas. Sow Good expects to begin production in the first quarter of 2021. Investors are welcomed to visit www.thisissowgood.com to follow product launch updates.
Sow Good's unique food products are targeting the large, and growing, freeze-dried food products market. The global freeze-dried food products market is estimated by Technavio to total nearly $60B in 2020, with the United States representing almost 30% of the total. Technavio further projects market growth to continue at over 8% per year through 2024.
Sow Good management is well positioned to lead the Company's growth. As announced in October, Claudia and Ira Goldfarb joined Sow Good as CEO and Executive Chairman, respectively. The Goldfarb's have extensive experience with freeze-dried manufacturing and in building food product-focused companies. The Company further announced in October that it has appointed Greg Creed, a veteran restaurant executive, to the Company's Board of Directors. Mr. Creed most recently held the position of CEO of Yum! Brands, Inc., and previously led Taco Bell as its CEO.
(BCTXF)MC 3 m- O/S 779 k --HUGE Cancer Pipeline with Phase 3 (Breast Cancer) to start later THIS year /Nasdaq listing imminent / UNKNOWN stock = I think this low float bomb is going to explode very hard on good news
New Presentation
https://briacell.com/wp-content/uploads/2021/02/BriaCell-Presentation-2021-February.pdf
(APLIF)$1-CHEAPEST Covid PHASE 3 GEM with results coming NEXT MONTH ,Drug is partnered with big pharma Dr Reddy (RDY) a potential 10 BAGGER here guys
(APLIF) 0.93 /Covid 19 PHASE 3 results NEXT month =Potential 10+ Bagger here guys ...Unknown stock
Covid 19 Phase 3 Program partnered with big pharma Dr Reddy (RDY )
Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19
https://finance.yahoo.com/news/appili-therapeutics-provides-enrollment-phase-111700402.html
The Company is prioritizing resources on the pivotal study and expects to provide interim data readout by late March 2021
(APLIF) 0.93 /Covid 19 PHASE 3 results NEXT month =Potential 10+ Bagger here guys ...Unknown stock
Covid 19 Phase 3 Program partnered with big pharma Dr Reddy (RDY )
Appili Therapeutics Provides Enrollment Update for Its Phase 3 PRESECO Trial Evaluating the Oral Antiviral Favipiravir as an Early Treatment in COVID-19
https://finance.yahoo.com/news/appili-therapeutics-provides-enrollment-phase-111700402.html
The Company is prioritizing resources on the pivotal study and expects to provide interim data readout by late March 2021
(ADOM) 0.50 /CHEAPEST EV gem EXPLODINGGGGGGG this has potential to explode toward 5 dollars
(ADOM) 0.50 /CHEAPEST EV gem EXPLODINGGGGGGG this has potential to explode toward 5 dollars
(ADOM)0.48-CHEAPEST EV stock potential 10 or even 20 Bagger guys
https://adomanielectric.com/products/
(CYTH) MC $38 m EXPLODINGGGGG after SAVA reporting some positive Alzheimer data . CYTH is much better gem than the $4 billion dollar company SAVA which only has a Phase 2 Program while CYTH has already a BIG Orphan Drug ready for Phase 3 and a Alzheimer program to start Phase 2 trial soon .
CYTH next SAVA EXPLODINGGGGGGG its the CHEAPEST Alzheimer gem in the biotech sector potential 1000% Gem guys